drugset
drugset / Trial / NCT00368459

Raloxifene for Women With Alzheimer's Disease

NCT00368459 ↗

Phase 2 Completed 42 enrolled Stanford University Indiana University · collabKaiser Permanente · collabSouthern Illinois University · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.

Timeline

Start
2006-08
Primary completion
2011-03
Completion
2012-01

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Raloxifene vs Placebo; p >0.1; ANCOVA NCT00368459 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Raloxifene Other / unclassified 120 mg Oral

Indications

Alzheimer disease